Evidence map›Paper›PMID 34648291›Full record

ArticleJournal of the American Chemical Society2021

Predicting Mutational Effects on Receptor Binding of the Spike Protein of SARS-CoV-2 Variants.

Chen Bai, Junlin Wang, Geng Chen, Honghui Zhang, Ke An, Peiyi Xu, Yang Du, Richard D Ye, Arjun Saha, Aoxuan Zhang and 1 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Exploring the Activation Process of the Glycine Receptor.Journal of the American Chemical Society · 2024
    Article
  7. Article
  8. Exploring the activation mechanism of metabotropic glutamate receptor 2.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chen BaiSchool of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Shenzhen 518172, P. R. China.ORCID 0000-0003-4560-3019
Junlin WangSchool of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Shenzhen 518172, P. R. China.
Geng ChenSchool of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Shenzhen 518172, P. R. China.
Honghui ZhangSchool of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Shenzhen 518172, P. R. China.
Ke AnSchool of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Shenzhen 518172, P. R. China.
Peiyi XuSchool of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Shenzhen 518172, P. R. China.
Yang DuSchool of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Shenzhen 518172, P. R. China.
Richard D YeSchool of Life and Health Sciences, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Shenzhen 518172, P. R. China.ORCID 0000-0002-2164-5620
Arjun SahaDepartment of Chemistry, University of Southern California, Los Angeles, California 90089-1062, United States.ORCID 0000-0003-1198-1820
Aoxuan ZhangDepartment of Chemistry, University of Southern California, Los Angeles, California 90089-1062, United States.
Arieh WarshelDepartment of Chemistry, University of Southern California, Los Angeles, California 90089-1062, United States.ORCID 0000-0001-7971-5401

Funding

Multiscale Simulations of Biological Systems and ProcessesR35GM122472 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ARIEH WARSHEL · 2017 to 2026
$5.0M
NIGMS NIH HHS R35 GM122472
6 · The paper itself

Abstract

The pandemic caused by SARS-CoV-2 has cost millions of lives and tremendous social/financial loss. The virus continues to evolve and mutate. In particular, the recently emerged "UK", "South Africa", and Delta variants show higher infectivity and spreading speed. Thus, the relationship between the mutations of certain amino acids and the spreading speed of the virus is a problem of great importance. In this respect, understanding the mutational mechanism is crucial for surveillance and prediction of future mutations as well as antibody/vaccine development. In this work, we used a coarse-grained model (that was used previously in predicting the importance of mutations of N501) to calculate the free energy change of various types of single-site or combined-site mutations. This was done for the UK, South Africa, and Delta mutants. We investigated the underlying mechanisms of the binding affinity changes for mutations at different spike protein domains of SARS-CoV-2 and provided the energy basis for the resistance of the E484 mutant to the antibody m396. Other potential mutation sites were also predicted. Furthermore, the in silico predictions were assessed by functional experiments. The results establish that the faster spreading of recently observed mutants is strongly correlated with the binding-affinity enhancement between virus and human receptor as well as with the reduction of the binding to the m396 antibody. Significantly, the current approach offers a way to predict new variants and to assess the effectiveness of different antibodies toward such variants.

Indexed as

MutationBinding SitesCOVID-19HumansModels, MolecularSARS-CoV-2Spike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID34648291
PMCPMC8525340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.